Your Input: | |||||
ADAM23 | Disintegrin and metalloproteinase domain-containing protein 23. (833 aa) | ||||
SLC1A2 | Amino acid transporter. (565 aa) | ||||
GRM3 | Metabotropic glutamate receptor 3 isoform X1. (879 aa) | ||||
CADM3 | Cell adhesion molecule 3-like. (409 aa) | ||||
NPTN | Neuroplastin isoform X1. (398 aa) | ||||
ADCY8 | Adenylate cyclase; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1250 aa) | ||||
ATP2B1 | Calcium-transporting ATPase; This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium. (1220 aa) | ||||
GRIK4 | Glutamate receptor ionotropic, kainate 4. (919 aa) | ||||
PRRT2 | LOW QUALITY PROTEIN: proline-rich transmembrane protein 2. (411 aa) | ||||
DRD2 | D(2) dopamine receptor isoform X2; Belongs to the G-protein coupled receptor 1 family. (443 aa) | ||||
CDH2 | Cadherin-2 isoform X1; Cadherins are calcium-dependent cell adhesion proteins. (906 aa) | ||||
FXYD6 | FXYD domain-containing ion transport regulator; Belongs to the FXYD family. (143 aa) | ||||
EFNB3 | LOW QUALITY PROTEIN: ephrin-B3; Belongs to the ephrin family. (356 aa) | ||||
EPHB2 | Ephrin type-B receptor 2 isoform X1. (964 aa) | ||||
KCNJ9 | LOW QUALITY PROTEIN: G protein-activated inward rectifier potassium channel 3. (469 aa) | ||||
PTPRS | Receptor-type tyrosine-protein phosphatase S isoform X2. (1948 aa) | ||||
LOC103079052 | LOW QUALITY PROTEIN: protocadherin-17-like. (1167 aa) | ||||
KCNJ3 | G protein-activated inward rectifier potassium channel 1 isoform X1. (501 aa) | ||||
EPHA4 | Ephrin type-A receptor 4-like isoform X1. (986 aa) | ||||
ERBB4 | Receptor protein-tyrosine kinase. (1308 aa) | ||||
CNR1 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] (472 aa) | ||||
LRFN3 | Leucine-rich repeat and fibronectin type-III domain-containing protein 3. (628 aa) |